Posts filed under ‘Hepatitis E’

EASL Clinical Practice Guidelines on hepatitis E virus infection. European Association for the Study of the Liver.

J Hepatol. 2018 Jun;68(6):1256-1271

Summary

Infection with hepatitis E virus (HEV) is a significant cause of morbidity and mortality, representing an important global health problem.

Our understanding of HEV has changed completely over the past decade. Previously, HEV was thought to be limited to certain developing countries.

We now know that HEV is endemic in most high-income countries and is largely a zoonotic infection.

Given the paradigm shift in our understanding of zoonotic HEV and that locally acquired HEV is now the commonest cause of acute viral hepatitis in many European countries, the focus of these Clinical Practice Guidelines will be on HEV genotype 3 (and 4).

FULL TEXT

https://www.journal-of-hepatology.eu/article/S0168-8278(18)30155-7/fulltext

PDF

https://www.journal-of-hepatology.eu/article/S0168-8278(18)30155-7/pdf

Advertisements

March 21, 2019 at 8:27 am

Seroprevalence and risk factors of Hepatitis E infection in Jordan’s population: First report

International Journal of Infectious Diseases January 2018 V.66 P.121–125

Mohammad M. Obaidat, Amira A. Roess

Highlights

  • Seroprevalce, risk factors and zoonotic potential of HEV were studied.
  • HEV antibodies occurs at high prevalence (30.9%) overall in Jordan.
  • HEV infection associates with age and eating undercooked meat.
  • Owning camels increased the odds of HEV seropositivity.

Objectives

Hepatitis E virus (HEV) is hyperendemic in many countries, but data on this virus are not available in Jordan. This study determined the seroprevalence, risk factors and zoonotic potential of HEV in a Jordanian population.

Methods

A total of 450 sera samples from 8 different governorates were tested for HEV-IgG. A pre-tested and validated questionnaire was used to collect risk factor data including animal interaction and environmental exposures.

Results

The overall seroprevalence was 30.9%. Eating undercooked meat was significantly associated with HEV seropositivity (OR = 2.06, 95%CI 1.04–4.06) after controlling for age, gender, travel history and source of water. Age was also associated with HEV seropositivity; the youngest (≤14 years of age) and oldest age groups (60 and 80 years of age) had the highest prevalence (45.5% and 53.2%, respectively), compared to those between 20 to 29 years of age and 30 to 39 years of age (20.2 and 15.2%, respectively), although the small sample size among the youngest group tempers this association. There was evidence of a marginal association between owning camels and an increased odds of HEV seropositivity. Place of residence and source of drinking water were not associated with infection.

Conclusion

This is the first study to report HEV seroprevalence in Jordan and shows that HEV exposure is high in Jordan. Surveillance for acute and chronic Hepatitis E is needed to estimate the frequency of the actual disease.

abstract

http://www.ijidonline.com/article/S1201-9712(17)30297-7/fulltext

PDF

http://www.ijidonline.com/article/S1201-9712(17)30297-7/pdf

February 10, 2018 at 9:14 am

Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: Preliminary Observations

International Journal of Infectious Diseases November 2017 V.64 N. P.4–8

Marie Amougou Atsama, Paul Jean Adrien Atangana, Dominique Noah Noah, Paul Fewou Moundipa, Pascal Pineau, Richard Njouom

Abstract

Objectives

To determine the seroprevalence of hepatitis E virus (HEV) infection in patients with chronic hepatitis and/or hepatocellular carcinoma (HCC) and to assess its potential consequences for disease progression.

Methods

We conducted a prospective case-control study on patients with HCC hepatitis B or C related and non-HCC patients including patients with CLD and patients without clinical evidence of liver disease. Anti-HEV IgG and IgM were tested by ELISA using commercially available kits. Liver damage was assessed by alanine aminotransferase, aspartate aminotransferase, platelets and prothrombin measurements.

Results

We observed a significant anti-HEV IgG carriage in HCC patients compared to non-HCC subjects with CLD (41.8% vs 12.6%; P = 9.1 E-6; OR = 4.8, 95%CI: 2.3-10.6). HCC patients with HEV infection display more profound alterations of circulating liver enzymes, platelets count and prothrombin time than HCC patients without sero-reactivity to HEV.

Conclusion

Overall, this study indicates a high prevalence of HEV infection in Cameroonian patients with CLD and HCC. These data suggest either that patients with liver tumors are more susceptible to hepeviral infection or that, in a tropical context, HEV might promote the progression of liver diseases towards tumor.

abstract

http://www.ijidonline.com/article/S1201-9712(17)30216-3/fulltext

PDF

http://www.ijidonline.com/article/S1201-9712(17)30216-3/pdf

February 9, 2018 at 1:17 pm

Revisiones – Diagnóstico microbiológico de las hepatitis virales

Enf Infecc & Microbiol. Clínica Noviembre 2015 V.33 N.9 e53-e62

Roberto Alonso, Antonio Aguilera, Juan Córdoba, Antonio Fuertes

a Servicio de Microbiología y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, España

b Servicio de Microbiología, Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, España

c Servicio de Microbiología, Hospital Universitari i Politècnic La Fe, Valencia, España

d LABCO QualityDiagnostics, Madrid, España

La inflamación hepática o hepatitis tiene causas diversas, tanto infecciosas como no infecciosas. Entre las primeras, cabe destacar la etiología viral que es la causa de, al menos, la mitad de todas las hepatitis en el mundo.

Se han descrito distintos virus con tropismo primario por el tejido hepático. Estos microorganismos se han ido nombrando sucesivamente con las letras del abecedario: A, B, C, D, E y G.

El objetivo de este artículo es revisar este grupo heterogéneo de virus en sus aspectos más básicos, sus implicaciones clínicas, su tratamiento, las principales medidas preventivas frente a estas infecciones y, con especial interés, las aproximaciones diagnósticas, tanto serológicas como moleculares, que se utilizan para su detección, cuantificación y caracterización

PDF

http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90443319&pident_usuario=0&pcontactid=&pident_revista=28&ty=51&accion=L&origen=zonadelectura&web=www.elsevier.es&lan=es&fichero=28v33n09a90443319pdf001.pdf

February 20, 2017 at 3:26 pm

Pregnancy and susceptibility to infectious diseases.

Infect Dis Obstet Gynecol. 2013;2013:752852.

Sappenfield E1, Jamieson DJ, Kourtis AP.

Author information

1Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.

Abstract

To summarize the literature regarding susceptibility of pregnant women to infectious diseases and severity of resulting disease, we conducted a review using a PubMed search and other strategies. Studies were included if they reported information on infection risk or disease outcome in pregnant women.

In all, 1454 abstracts were reviewed, and a total of 85 studies were included. Data were extracted regarding number of cases in pregnant women, rates of infection, risk factors for disease severity or complications, and maternal outcomes.

The evidence indicates that pregnancy is associated with increased severity of some infectious diseases, such as influenza, malaria, hepatitis E, and herpes simplex virus (HSV) infection (risk for dissemination/hepatitis); there is also some evidence for increased severity of measles and smallpox.

Disease severity seems higher with advanced pregnancy. Pregnant women may be more susceptible to acquisition of malaria, HIV infection, and listeriosis, although the evidence is limited. These results reinforce the importance of infection prevention as well as of early identification and treatment of suspected influenza, malaria, hepatitis E, and HSV disease during pregnancy.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723080/pdf/IDOG2013-752852.pdf

August 15, 2015 at 5:29 pm

Hepatitis E virus: a zoonosis adapting to humans

Antimicrob. Chemother. (2010) 65(5): 817-821

PDF

http://jac.oxfordjournals.org/content/65/5/817.full.pdf+html

November 21, 2014 at 8:44 am

Outbreak of Hepatitis E in Urban Bangladesh Resulting in Maternal and Perinatal Mortality

Clinical Infectious Diseases September 1, 2014 V.59 N.5 P.658-665

Emily S. Gurley1, M. Jahangir Hossain1, Repon C. Paul1, Hossain M. S. Sazzad1, M. Saiful Islam1, Shahana Parveen1, Labib I. Faruque1, Mushtuq Husain2, Khorshed Ara2, Yasmin Jahan2, Mahmudur Rahman2, and Stephen P. Luby1,3

1icddr,b (International Center for Diarrhoeal Disease Research, Bangladesh)

2 Ministry of Health and Family Welfare, Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh

3Global Disease Detection Branch, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia

Correspondence: Emily S. Gurley, MPH, PhD, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh (egurley@icddrb.org).

Background

Hepatitis E virus (HEV) causes outbreaks of jaundice associated with maternal mortality. Four deaths among pregnant women with jaundice occurred in an urban community near Dhaka, Bangladesh, in late 2008 and were reported to authorities in January 2009. We investigated the etiology and risk factors for jaundice and death.

Methods

Field workers identified suspected cases, defined as acute onset of yellow eyes or skin, through house-to-house visits. A subset of persons with suspected HEV was tested for immunoglobulin M (IgM) antibodies to HEV to confirm infection. We used logistic regression analysis to identify risk factors for HEV disease and for death. We estimated the increased risk of perinatal mortality associated with jaundice during pregnancy.

Results

We identified 4751 suspected HEV cases during August 2008–January 2009, including 17 deaths. IgM antibodies to HEV were identified in 56 of 73 (77%) case-patients tested who were neighbors of the case-patients who died. HEV disease was significantly associated with drinking municipally supplied water. Death among persons with HEV disease was significantly associated with being female and taking paracetamol (acetaminophen). Among women who were pregnant, miscarriage and perinatal mortality was 2.7 times higher (95% confidence interval, 1.2–6.1) in pregnancies complicated by jaundice.

Conclusions

This outbreak of HEV was likely caused by sewage contamination of the municipal water system. Longer-term efforts to improve access to safe water and license HEV vaccines are needed. However, securing resources and support for intervention will rely on convincing data about the endemic burden of HEV disease, particularly its role in maternal and perinatal mortality.

PDF

http://cid.oxfordjournals.org/content/59/5/658.full.pdf+html

 

October 15, 2014 at 8:23 am

Older Posts


Calendar

May 2019
M T W T F S S
« Apr    
 12345
6789101112
13141516171819
20212223242526
2728293031  

Posts by Month

Posts by Category